Biotricity, Inc.
BTCY
$0.55
$0.02013.79%
| Weiss Ratings | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.25 | |||
| Price History | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 44.74% | |||
| 60-Day Total Return | 91.64% | |||
| 90-Day Total Return | 22.22% | |||
| Year to Date Total Return | 77.42% | |||
| 1-Year Total Return | -58.65% | |||
| 2-Year Total Return | -85.68% | |||
| 3-Year Total Return | -96.00% | |||
| 5-Year Total Return | -91.43% | |||
| 52-Week High % Change | -68.27% | |||
| 52-Week Low % Change | 184.89% | |||
| Price | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.67 | |||
| 52-Week Low Price | $0.19 | |||
| 52-Week Low Price (Date) | Oct 02, 2024 | |||
| 52-Week High Price (Date) | Mar 20, 2024 | |||
| Valuation | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 13.20M | |||
| Enterprise Value | 40.25M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.08 | |||
| Earnings Per Share Growth | -37.97% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.97 | |||
| Price/Book (Q) | -0.41 | |||
| Enterprise Value/Revenue (TTM) | 3.03 | |||
| Price | $0.55 | |||
| Enterprise Value/EBITDA (TTM) | -8.69 | |||
| Enterprise Value/EBIT | -8.68 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 24.23M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -0.22% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (800) 590-4155 | |||
| Address | 203 Redwood Shores Parkway Redwood City, CA 94065 | |||
| Website | www.biotricity.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -34.96% | |||
| Profit Margin | -80.41% | |||
| Management Effectiveness | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -50.53% | |||
| Return on Equity | -- | |||
| Income Statement | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 13.27M | |||
| Total Revenue (TTM) | 13.27M | |||
| Revenue Per Share | $0.55 | |||
| Gross Profit (TTM) | 9.86M | |||
| EBITDA (TTM) | -4.63M | |||
| EBIT (TTM) | -4.64M | |||
| Net Income (TTM) | -10.67M | |||
| Net Income Avl. to Common (TTM) | -10.69M | |||
| Total Revenue Growth (Q YOY) | 21.73% | |||
| Earnings Growth (Q YOY) | 56.23% | |||
| EPS Diluted (TTM) | -1.08 | |||
| EPS Diluted Growth (Q YOY) | 83.96% | |||
| Balance Sheet | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.06M | |||
| Cash Per Share (Q) | $0.08 | |||
| Total Current Assets (Q) | 4.86M | |||
| Total Preferred Equity (Q) | 3.65 | |||
| Total Equity (Q) | -28.29M | |||
| Current Ratio (Q) | 0.230 | |||
| Book Value Per Share (Q) | -$1.30 | |||
| Total Assets (Q) | 5.99M | |||
| Total Current Liabilities (Q) | 21.14M | |||
| Total Debt (Q) | 25.46M | |||
| Total Liabilities (Q) | 34.28M | |||
| Total Common Equity (Q) | -31.94M | |||
| Cash Flow | BTCY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 3.55M | |||
| Net Change in Cash (TTM) | 424.50K | |||
| Levered Free Cash Flow (TTM) | -3.03M | |||
| Cash from Operations (TTM) | -3.15M | |||
